title: [Primary pancreatic cystic neoplasms--diagnosis and treatment].
abstract: The paper's purpose is to analyze the diagnosis and treatment methods of primary pancreatic cystic neoplasms. Between 1996-2007, 10 patients (3 male and 7 female), ages between 30 and 71, were committed and surgically treated in the Surgical Unit of Colentina Clinical Hospital of primary pancreatic cystic neoplasms: 2 serous cystadenomas (SCAs) and 8 mucinous cystic neoplasms (MCNs) (in one case there were liver and peripancreatic lymph nodes metastases). Following clinical and paraclinical evaluation, patients with serous cystadenomas received distal pancreatectomy and splenectomy, and MCNs patients received cephalic duodenopancreatectomy (3 cases), distal pancreatectomy and splenectomy (3 cases), segmental corporeo-caudal pancreatectomy (1 case) and choledocoduodenostomy and gastrojejunostomy (1 case). In patients with serous cystadenomas the post-operatory mortality and morbidity were null, and the long-term prognostic excellent, both patients, after 26 months and 5 years respectively, being in good health, with no evidence of illness. In patients with mucinous cystic neoplasms the post-operatory mortality was null, the post-operatory morbidity was 37.5% and the global survival rate was 50% in 5 years and 66.66% in 3 years. Primary cystic neoplasms are lesions that can be surgically treated, with good results. Surgical resection is the ideal therapeutic solution, while palliative surgeries alternatives are done in exceptional situations.
authors.affiliation: Clinica de Chirurgie, Spitalul Clinic Colţea, Bucureşti. nikas_iustin@yahoo.com
authors.forename: N I
authors.initials: NI
authors.lastname: Berevoescu
authors.forename: S
authors.initials: S
authors.lastname: Simion
authors.forename: A
authors.initials: A
authors.lastname: Croitoru
authors.forename: S
authors.initials: S
authors.lastname: Bacaliuc
authors.forename: S
authors.initials: S
authors.lastname: Tigan
mesh_terms: D000328:Adult; D000368:Aged; D003536:Cystadenocarcinoma / Q000175:diagnosis* / Q000401:mortality / Q000601:surgery*; D018282:Cystadenocarcinoma, Mucinous / Q000175:diagnosis / Q000601:surgery; D018284:Cystadenocarcinoma, Serous / Q000175:diagnosis / Q000601:surgery; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010180:Pancreatectomy / Q000379:methods*; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000601:surgery*; D016577:Pancreaticoduodenectomy / Q000379:methods*; D012189:Retrospective Studies; D018570:Risk Assessment; D013156:Splenectomy; D016019:Survival Analysis; D016896:Treatment Outcome